TY
Teresa L. Young
See Remarks

Teresa L. Young insider trades: Seres Therapeutics (MCRB) stock sales

See Remarks, Seres Therapeutics Last trade Feb 15, 2026 18 Form 4 filings
$19K
Sold, last 12 months
2 sales
$0
Bought, last 12 months
0 buys
12
Open-market trades
since 2023
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Teresa reports to the SEC

Open-market buys and sales

12 trades reported on SEC Form 4, newest first

DateStockTypeValue
Feb 15, 2026MCRB↓ Sell$635
Nov 15, 2025MCRB↓ Sell$18K
Aug 18, 2025MCRB↓ Sell$982
May 16, 2025MCRB↓ Sell$459
Feb 18, 2025MCRB↓ Sell$3K
Nov 18, 2024MCRB↓ Sell$398
Oct 28, 2024MCRB↓ Sell$2K
Aug 16, 2024MCRB↓ Sell$612
Aug 5, 2024MCRB↓ Sell$27K
May 15, 2024MCRB↓ Sell$661
Feb 16, 2024MCRB↓ Sell$4K
Oct 30, 2023MCRB↓ Sell$4K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other MCRB insiders

Open-market trades in the last 12 months

About Teresa L. Young's insider trades

Teresa L. Young is See Remarks at Seres Therapeutics (MCRB). Since Oct 30, 2023, Teresa has reported no open-market purchases and 12 sales worth $61K on SEC Form 4. In the last 12 months: 2 sales ($19K).

Their filings also include option exercises (12 filings), grants and awards (8 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MCRB insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.